The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.10 - Manufacture Of Basic Pharmaceutical Products
100 jobs Number of planned job creations
Announcement Date
8 January 2025
Employment effect (start)
8 January 2025
Foreseen end date
Description
The life-science company Polypeptide announced in January of 2025 that they will be employing about 100 new workers to meet the increased demand for their Peptide products, which are used in fat loss and diabetic pharmaceutical products. The company stated that the entire business of fat loss medication is in a boom period. The company is investing about 100 million euros as part of their efforts to double the production capacity at the factory located in Limhamn, just outside of the southern Swedish city of Malmö.
Polypeptide started as a company in Malmö and is now active in several countries in Europe, USA and India. The company employs about 1300 employees globally.
Eurofound (2025), Polypeptide, Business expansion in Sweden, factsheet number 202202, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/202202.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
